Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. COO
COO logo

COO Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Cooper Companies Inc (COO) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
65.910
1 Day change
1.32%
52 Week Range
89.830
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Cooper Companies Inc (COO) is not a strong buy at the moment for a beginner investor with a long-term focus. While there are some positive catalysts, such as Congress buying activity and a potential for a CSI sale, the mixed analyst ratings, lowered price targets, and lack of strong trading signals suggest holding off on immediate investment. The stock's technical indicators are neutral, and there is no clear momentum to justify a buy at this time.

Technical Analysis

The MACD is positive and contracting (0.324), but the RSI is neutral at 49.94, indicating no clear trend. Moving averages are converging, and the stock is trading near its support level (S1: 65.492). Overall, the technicals suggest a neutral stance with no strong buy signal.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
6

Positive Catalysts

  • Congress trading data shows a recent purchase worth $0.8M, indicating confidence from influential figures.

  • Potential sale of the CSI business could unlock value.

  • Analysts note strategic actions like share buybacks and debt paydown, which could stabilize the stock.

Neutral/Negative Catalysts

  • Analysts have broadly lowered price targets, reflecting weaker growth expectations for FY

  • The company reduced its CooperVision outlook, particularly in APAC.

  • MedTech sector challenges, including slower growth and competitive risks, weigh on sentiment.

Financial Performance

No detailed financial data available for analysis, but Q2 revenue and EPS beat consensus by 3% and 11%, respectively. However, FY26 guidance was lowered, indicating a cautious outlook.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is mixed. Several firms (Needham, Stifel, Baird, Mizuho) maintain Buy or Outperform ratings but have lowered price targets to the $85 range. Others, like JPMorgan and Citi, are Neutral, while Goldman Sachs has a Sell rating with a $61 price target. Analysts highlight strategic optionality but express concerns over weaker growth projections.

Wall Street analysts forecast COO stock price to rise
12 Analyst Rating
Wall Street analysts forecast COO stock price to rise
7 Buy
4 Hold
1 Sell
Moderate Buy
Current: 65.050
sliders
Low
73
Averages
90.33
High
100
Current: 65.050
sliders
Low
73
Averages
90.33
High
100
Needham
Buy
downgrade
$101 -> $86
AI Analysis
2026-06-05
Reason
Needham
Price Target
$101 -> $86
AI Analysis
2026-06-05
downgrade
Buy
Reason
Needham lowered the firm's price target on Cooper Companies to $86 from $101 and keeps a Buy rating on the shares. The company's Q2 revenue and EPS beat consensus by 3% and 11%, respectively, but management lowered its FY26 revenue guidance given a softer second-half CooperVision outlook in APAC, the analyst tells investors in a research note. The firm retains its positive stance given the company's solid operating expense leverage and strategic actions serving as a potential catalyst.
JPMorgan
Robbie Marcus
Neutral
downgrade
$80 -> $71
2026-06-05
Reason
JPMorgan
Robbie Marcus
Price Target
$80 -> $71
2026-06-05
downgrade
Neutral
Reason
JPMorgan analyst Robbie Marcus lowered the firm's price target on Cooper Companies to $71 from $80 and keeps a Neutral rating on the shares. The company reported a better than expected fiscal Q2 report but lowered its CooperVision outlook, the analyst tells investors in a research note. However, JPMorgan believes Cooper's strategic review and buyback messaging "should be enough to put a floor on the share price."
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for COO
Unlock Now

People Also Watch